血栓通注射液治疗老年性黄斑变性的疗效观察

The Efficacy of Xueshuantong Injection on the Treat-ment of Age-related Macular Degeneration

目的 观察血栓通注射液治疗老年性黄斑变性的疗效。 方法 将176例患者随机分为两组,观察组90例采用血栓通注射液(血栓通420mg)加入生理盐水静脉滴注,每天1次,15天为一疗程,停用1周后,重复使用;对照组86例采用血管扩张剂及支持疗法,两组病例均治疗40～45天后进行疗效比较。 结果 观察组治愈、好转、无效病例分别为50、28、12例,对照组分别为10、30、46例。观察组疗效优于对照组(X2=30.30,P<0.01)。结论血栓通注射液治疗老年性黄斑变性具有较好的疗效。

Objective To investigate the therapeutic effect of Xueshuantong Injection on treatmentof age-related macular degeneration. Methods 176 cases of age-related macular degeneration wereseparated into two groups, 90 cases of the observation group treated with Xueshuantong; 86 cases of thecontrol group treated with vasodilator, after 40～45days, to investigate the therapeutic effect of thesetwo groups. Results These 90 cases of the observation group treated with Xueshuantong. 50 cases cured,28 cases turned better, 12 failed. The other 86 cases of the control group treated with vasodilator,10 cases cured, 30 cases turned better, 46 failed. There are statistically difference between two groups(P<0.01﹚.Conclusion Xueshuantong Injection is an efficacious cure on the treatment of age-relatedmacular degeneration.